CoreWeave (CRWV) CDO logs RSU vesting, tax and trust share sales
Rhea-AI Filing Summary
CoreWeave, Inc. Chief Development Officer Brannin McBee reported a mix of RSU vesting and share sales in Class A Common Stock. He exercised restricted stock units covering 121,118 shares of Class A Common Stock at a conversion price of $0.00 per share, increasing his direct equity stake.
A total of 56,707 directly held Class A shares were sold in an open-market transaction at a weighted average price of $95.69 per share to satisfy tax withholding obligations related to RSU vesting. Following these transactions, McBee directly holds 379,970 shares of Class A Common Stock. Indirectly, the Canis Major SM Trust holds 52,477 Class A shares, and several grantor retained annuity trusts and family LLCs hold Class B Common Stock that is convertible into Class A, including 1,582,773 underlying Class A shares through the Canis Major 2026 GRAT.
Positive
- None.
Negative
- None.
Insights
Routine RSU vesting with tax-driven and pre-planned sales; overall a neutral, mixed transaction.
Brannin McBee, Chief Development Officer of CoreWeave, reported exercising restricted stock units into 121,118 shares of Class A Common Stock at a conversion price of $0.00. These are standard equity compensation events, moving value from derivative RSUs into actual shares and increasing his directly held stock position.
He also reported selling 56,707 directly held Class A shares at a weighted average of about $95.69 per share. A footnote states this sale was to satisfy tax withholding obligations arising from RSU vesting and was effected under a Rule 10b5-1 trading plan adopted on March 5, 2026, which indicates a pre-planned, mechanical disposition rather than a discretionary market-timing decision.
Additional small open-market sales occurred in an indirect account, the Canis Major SM Trust, while several grantor retained annuity trusts and family LLCs continue to hold Class B Common Stock convertible on a one-for-one basis into Class A, including 1,582,773 underlying Class A shares via the Canis Major 2026 GRAT. Overall, the filing shows continued substantial exposure to CoreWeave equity, and given the tax and pre-planned nature of the sales, the net signal is neutral.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 109,380 | $0.00 | -- |
| Exercise | Restricted Stock Units | 11,738 | $0.00 | -- |
| Exercise | Class A Common Stock | 109,380 | $0.00 | -- |
| Exercise | Class A Common Stock | 11,738 | $0.00 | -- |
| Sale | Class A Common Stock | 56,707 | $95.69 | $5.43M |
| Sale | Class A Common Stock | 23 | $90.227 | $2K |
| Sale | Class A Common Stock | 31 | $91.399 | $3K |
| Sale | Class A Common Stock | 64 | $92.0602 | $6K |
| Sale | Class A Common Stock | 31 | $93.179 | $3K |
| Sale | Class A Common Stock | 60 | $94.2813 | $6K |
| Sale | Class A Common Stock | 237 | $95.3758 | $23K |
| Sale | Class A Common Stock | 38 | $96.0639 | $4K |
| Sale | Class A Common Stock | 11 | $96.9636 | $1K |
| Sale | Class A Common Stock | 5 | $98.31 | $491.55 |
| holding | Class B Common Stock | -- | -- | -- |
| holding | Class B Common Stock | -- | -- | -- |
| holding | Class B Common Stock | -- | -- | -- |
| holding | Class B Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
Footnotes (1)
- The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 5, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.71 to $90.67, inclusive. The reported securities are directly held by the Canis Major SM Trust (the "Canis Trust"), an irrevocable trust with a third-party trustee, of which the reporting person's minor child is beneficiary. The reporting person has the power to remove and replace the Canis Trust's trustee. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.75 to $91.74, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.75 to $92.73, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.79 to $93.78, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.80 to $94.7950, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.80 to $95.79, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.80 to $96.77, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.81 to $97.80, inclusive. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon settlement. The reported transaction represents shares of Class A Common Stock of the Issuer sold to satisfy the reporting person's tax withholding obligations, which were incurred in connection with the vesting and settlement of restricted stock units. The reported securities are directly held of record by the reporting person's child. Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation. The reported securities are directly held by the Canis Major 2025 Family Trust LLC, of which the reporting person serves as manager. The reported securities are directly held by a grantor retained annuity trust, of which the reporting person is the sole trustee and beneficiary. The reported securities are directly held by the Canis Minor 2025 Family Trust LLC, of which the reporting person serves as manager. The reported securities are directly held by a grantor retained annuity trust, of which the reporting person's spouse is the sole beneficiary and trustee. The award vested or vests as to 1/16 of the total award on the last day of March, June, September, and December, subject to the reporting person's continued service to the Issuer on each vesting date. The first tranche time-vested on March 31, 2025, and such vested shares were subsequently settled on May 31, 2025, pursuant to a deferral approved by the compensation committee of the Issuer's board of directors. These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date. The award vested or vests as to 1/16 of the total award quarterly on the last day of June, September, December, and March, subject to the reporting person's continued service to the Issuer on each vesting date, with the first tranche vesting on June 30, 2025.